Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis
- 1Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 2Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Cancer Dormancy Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA.
- 3Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 4Cancer Dormancy Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK.
- 5Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
- 6Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Cancer Dormancy Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA.
- 7Cancer Immunity Laboratory, Molecular Oncology Program, Spanish National Cancer Centre, Madrid, Spain.
- 8Cancer Dormancy Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA.
- 9Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 0Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tissue-resident alveolar macrophages induce dormancy in breast cancer cells through transforming growth factor-beta 2 (TGF-β2) signaling, preventing lung metastasis. Downregulation of this TGF-β2 pathway allows cancer cells to awaken and proliferate.
Area Of Science
- Oncology
- Immunology
- Cell Biology
Background
- Breast cancer cells can disseminate to the lungs and remain dormant.
- Mechanisms controlling breast cancer cell dormancy in the lungs are not fully understood.
- Tissue-resident alveolar macrophages are implicated in suppressing metastasis.
Purpose Of The Study
- To investigate the role of alveolar macrophages in maintaining breast cancer cell dormancy in the lungs.
- To elucidate the molecular mechanisms by which alveolar macrophages suppress cancer cell proliferation.
- To identify signaling pathways involved in the transition from dormancy to active metastasis.
Main Methods
- Ligand-receptor mapping to identify molecular interactions.
- Intravital imaging to visualize macrophage-cancer cell dynamics in vivo.
- Experimental depletion of alveolar macrophages.
- Genetic manipulation of TGF-β2 receptor expression in cancer cells.
Main Results
- Alveolar macrophages express transforming growth factor-beta 2 (TGF-β2).
- TGF-β2 signaling, mediated by the TGF-βRIII receptor on cancer cells, maintains cancer cell dormancy.
- Depletion of alveolar macrophages or loss of TGF-βRIII in cancer cells leads to metastatic awakening.
- Aggressive breast cancer cells evade dormancy by downregulating TGF-βRIII or avoiding macrophage interaction.
Conclusions
- Alveolar macrophages function as a critical immune barrier against breast cancer lung metastasis.
- TGF-β2 signaling is essential for macrophage-mediated suppression of cancer cell growth.
- Downregulation of the TGF-β2 pathway enables breast cancer cells to overcome dormancy and proliferate, leading to overt metastasis.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

